BibTex format
@inproceedings{Richard:2020:10.1182/blood-2020-137154,
author = {Richard, S and Chari, A and Delimpasi, S and Simonova, M and Spicka, I and Pour, L and Kryachok, I and Dimopoulos, MA and Pylypenko, H and Auner, HW and Leleu, X and Doronin, VA and Usenko, G and Hajek, R and Benjamin, R and Dolai, TK and Sinha, DK and Venner, CP and Garg, M and Stevens, DA and Quach, H and Jagannath, S and Moreau, P and Levy, MY and Badros, AZ and Anderson, LD and Bahlis, NJ and Facon, T and Mateos, M-V and Cavo, M and Chang, H and Landesman, Y and Joshi, AA and Chai, Y and Arazy, M and Shah, J and Shacham, S and Kauffman, MG and Grosicki, S and Richardson, PG},
doi = {10.1182/blood-2020-137154},
publisher = {AMER SOC HEMATOLOGY},
title = {Once Weekly Selinexor, Bortezomib, and Dexamethasone (SVd) Versus Twice Weekly Bortezomib and Dexamethasone (Vd) in Relapsed or Refractory Multiple Myeloma: High-Risk Cytogenetic Risk Planned Subgroup Analyses from the Phase 3 Boston Study},
url = {http://dx.doi.org/10.1182/blood-2020-137154},
year = {2020}
}